- Home
- Advocacy
- Latest News and Practice Data
- Drs. Booth, Gibson join panel to advocate for molecular testing coverage
As part of the CAP's ongoing advocacy, members Joanna Gibson, MD, PhD, FCAP, and Adam Booth, MD, FCAP, were part of eleven panelists who participated in a discussion of Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, Neoplasia on September 4.
The meeting was hosted by four Medicare Administrative Contractors (MACs) Palmetto GBS, Noridian Healthcare Solutions, CIGNA Government Services, and Wisconsin Physicians Service. Currently, these MACs do not cover molecular testing to detect changes in the cells of the upper digestive tract.
Dr. Gibson, Dr. Booth, and other panelists discussed the current medical evidence and clinical practice regarding testing to determine if the current policy should allow for molecular testing.